Saluja A K, Donovan E A, Yamanaka K, Yamaguchi Y, Hofbauer B, Steer M L
Department of Surgery, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.
Gastroenterology. 1997 Jul;113(1):304-10. doi: 10.1016/s0016-5085(97)70108-2.
BACKGROUND & AIMS: One of the central, unresolved issues in the pathogenesis of acute pancreatitis is the uncertainty regarding the mechanisms responsible for the premature intrapancreatic activation of digestive enzyme zymogens. The aim of the current study was to develop and characterize an in vitro system that might mimic the events leading to trypsinogen activation within the pancreas during pancreatitis.
Activation of trypsinogen in response to stimulation with cerulein was quantitated in isolated rat pancreatic acini.
Activation of trypsinogen was detected within 10 minutes of exposing isolated rat pancreatic acini, in Ca2+-containing buffer, to a supramaximally stimulating concentration of cerulein in vitro. Complete inhibition of pancreatic cathepsin B activity with E-64d, a specific, potent and irreversible cathepsin B inhibitor, prevents cerulein-induced in vitro trypsinogen activation.
In vitro activation of trypsinogen can be detected when pancreatic acini are exposed to a supramaximally stimulating dose of cerulein. The results using this in vitro system support the hypothesis that the appearance of active trypsin within the pancreas during the early stages of cerulein-induced pancreatitis reflects activation of trypsinogen by the lysosomal hydrolase cathepsin B.
急性胰腺炎发病机制中核心且未解决的问题之一是,对于胰酶原在胰腺内过早激活的相关机制尚不确定。本研究的目的是建立并描述一种体外系统,该系统可能模拟胰腺炎期间胰腺内导致胰蛋白酶原激活的事件。
在分离的大鼠胰腺腺泡中,定量检测蛙皮素刺激后胰蛋白酶原的激活情况。
在体外,将分离的大鼠胰腺腺泡置于含Ca2+的缓冲液中,用超最大刺激浓度的蛙皮素刺激后,10分钟内即可检测到胰蛋白酶原的激活。用E-64d(一种特异性、强效且不可逆的组织蛋白酶B抑制剂)完全抑制胰腺组织蛋白酶B的活性,可阻止蛙皮素诱导的体外胰蛋白酶原激活。
当胰腺腺泡暴露于超最大刺激剂量的蛙皮素时,可检测到体外胰蛋白酶原的激活。使用该体外系统得到的结果支持以下假说:在蛙皮素诱导的胰腺炎早期,胰腺内活性胰蛋白酶的出现反映了溶酶体水解酶组织蛋白酶B对胰蛋白酶原的激活。